Anzahl der Publikationen: 3
2021
Beyer, Jorg; Collette, Laurence; Sauve, Nicolas; Daugaard, Gedske; Feldman, Darren R.; Tandstad, Torgrim; Tryakin, Alexey; Stahl, Olof; Gonzalez-Billalabeitia, Enrique; De Giorgi, Ugo; Culine, Stephane; de Wit, Ronald; Hansen, Aaron R.; Bebek, Marko; Terbuch, Angelika; Albany, Costantine; Hentrich, Marcus; Gietema, Jourik A.; Negaard, Helene; Huddart, Robert A.; Lorch, Anja; Cafferty, Fay H.; Heng, Daniel Y. C.; Sweeney, Christopher J.; Winquist, Eric; Chovanec, Michal; Fankhauser, Christian; Stark, Daniel; Grimison, Peter; Necchi, Andrea; Tran, Ben; Heidenreich, Axel; Shamash, Jonathan; Sternberg, Cora N.; Vaughn, David J.; Duran, Ignacio; Bokemeyer, Carsten; Patrikidou, Anna; Cathomas, Richard; Assele, Samson und Gillessen, Silke
(2021):
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
In: Journal of Clinical Oncology, Bd. 39, Nr. 14: S. 1553-1562
Schmidinger, Manuela; Motzer, Robert J.; Rolland, Frederic; Straehler, Michael; Rink, Michael; Retz, Margitta; Csoszi, Tibor; McCaffrey, John A.; De Giorgi, Ugo; Caserta, Claudia; Duran, Ignacio; Benzaghou, Fawzi; Clary, Douglas O.; Albiges, Laurence; Choueiri, Toni K. und Tannir, Nizar M.
(2021):
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study.
In: Acta Oncologica, Bd. 61, Nr. 1: S. 52-57
2019
Rini, Brian I.; Powles, Thomas; Atkins, Michael B.; Escudier, Bernard; McDermott, David F.; Suarez, Cristina; Bracarda, Sergio; Stadler, Walter M.; Donskov, Frede; Lee, Jae Lyun; Hawkins, Robert; Ravaud, Alain; Alekseev, Boris; Staehler, Michael; Uemura, Motohide; De Giorgi, Ugo; Mellado, Begona; Porta, Camillo; Melichar, Bohuslav; Gurney, Howard; Bedke, Jens; Choueiri, Toni K.; Parnis, Francis; Khaznadar, Tarik; Thobhani, Alpa; Li, Shi; Piault-Louis, Elisabeth; Frantz, Gretchen; Huseni, Mahrukh; Schiff, Christina; Green, Marjorie C. und Motzer, Robert J.
(2019):
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
In: Lancet, Bd. 393, Nr. 10189: S. 2404-2415
Diese Liste wurde am
Sat Aug 10 18:28:12 2024 CEST
erstellt.